Clinical Trial Update: Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating doripenem for complicated urinary tract infections and pyelonephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyelonephritis
• Urinary Tract Infection

Drugs mentioned

• Doripenem (Doripenem)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Urinary Tract Infections, Pyelonephritis | Phase 3 | Status: COMPLETED